ZIM
HARP

Zacks Investment Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Zacks Investment Management’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,004
Closed -$22.4K – 742
2023
Q1 		$22.4K Buy
+3,004
New +$25.3K ﹤0.01% 621

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Zacks Investment Management's HARP Position: Q2 2023 in Review

Zacks Investment Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2023, closing a stake of 3,004 shares — an estimated $22.4K sold.

Zacks Investment Management first reported a position in HARP in Q1 2023 and held it in 1 quarter. The position peaked at $22.4K in Q1 2023. 44 funds tracked by Wall St. Rank hold HARP as of Q2 2023.

  • Zacks Investment Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Zacks Investment Management sold 3,004 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $22.4K.
  • Zacks Investment Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Zacks Investment Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $22.4K in Q1 2023.
  • 44 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Zacks Investment Management's 13F filing for Q2 2023, filed 15 Aug 2023.